Symbiotec Pharmalab Ltd Market Cap

Market Capitalization of Symbiotec Pharmalab Ltd

From Blinkx's GPT

No data available

Key Highlights

  • The Latest Trading Price of Symbiotec Pharmalab Ltd is ₹ 1095 as of 01 Sep 16:01 .
Image

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

Share Price

₹ 1095.95

107.95 (10.93%)

stock direction

Last updated on: Sep 01, 2026

Market Price of Symbiotec Pharmalab Ltd

1M

1Y

3Y

5Y

Monitoring Symbiotec Pharmalab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Symbiotec Pharmalab Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Symbiotec Pharmalab Ltd

Asset Value vs Market Value of Symbiotec Pharmalab Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Symbiotec Pharmalab Ltd

No data available

Historical P/E Ratio of Symbiotec Pharmalab Ltd

No data available

* All values are in %

Historical Revenue of Symbiotec Pharmalab Ltd

No data available

* All values are in crore

Historical EBITDA of Symbiotec Pharmalab Ltd

No data available

* All values are in crore

Historical Net Profit of Symbiotec Pharmalab Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Symbiotec Pharmalab Ltd

  • Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh.
  • Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing.
  • The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility.
  • It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.

Symbiotec Pharmalab Ltd News Hub

Symbiotec Pharmalab IPO ends with 71.26 times subcription

The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3

Read more

28 Aug 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for null Market Cap

What is the market cap of Symbiotec Pharmalab Ltd?

As of September 1, 2026, Symbiotec Pharmalab Ltd has a market capitalization of ₹0.0, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Symbiotec Pharmalab Ltd's market capitalization?

Symbiotec Pharmalab Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Symbiotec Pharmalab Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Symbiotec Pharmalab Ltd's market capitalization change?

Symbiotec Pharmalab Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions